Sandra Muntion
Overview
Explore the profile of Sandra Muntion including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
992
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valencia J, Yanez R, Muntion S, Fernandez-Garcia M, Martin-Rufino J, Zapata A, et al.
Front Immunol
. 2025 Mar;
16:1473788.
PMID: 40034706
Introduction: MSCs exhibit regenerative, anti-inflammatory and immunomodulatory properties due to the large amount of cytokines, chemokines and growth factors they secrete. MSCs have been extensively evaluated in clinical trials, however,...
2.
Muntion S, Sanchez-Luis E, Diez-Campelo M, Blanco J, Sanchez-Guijo F, De Las Rivas J
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39595975
In this paper, we present a comparative analysis of the transcriptomic profile of three different human cell types: hematopoietic stem cells (HSCs), bone marrow-derived mesenchymal stem cells (MSCs) and fibroblasts...
3.
Hamad-Alrashid H, Muntion S, Sanchez-Guijo F, Borrajo-Sanchez J, Parreno-Manchado F, Garcia-Cenador M, et al.
J Pers Med
. 2024 Nov;
14(11).
PMID: 39590567
Background/objectives: The therapeutic approach to bone mass loss and bone's limited self-regeneration is a major focus of research, emphasizing new biomaterials and cell therapy. Tissue bioengineering emerges as a potential...
4.
Ijurko C, Romo-Gonzalez M, Prieto-Bermejo R, Diez-Campelo M, Vidriales M, Muntion S, et al.
Biomark Res
. 2024 Oct;
12(1):128.
PMID: 39468687
Acute myeloid leukaemia (AML) is a highly heterogeneous malignancy, with a poor 5-year overall survival rate of approximately 30%. Consequently, the search for novel therapeutic strategies is ongoing, and the...
5.
Preciado S, Martinez-Villaluenga C, Rico D, Muntion S, Garcia-Macias M, Navarro-Bailon A, et al.
Nutrients
. 2023 Nov;
15(21).
PMID: 37960235
Graft-versus-host disease (GvHD) is a common and severe complication following allogeneic hematopoietic stem cell transplantation (HSCT). Its prevention and treatment is a major challenge. Ferulic acid (FA) has anti-inflammatory and...
6.
Ainciburu M, Ezponda T, Berastegui N, Alfonso-Pierola A, Vilas-Zornoza A, San Martin-Uriz P, et al.
Elife
. 2023 Jan;
12.
PMID: 36629404
Early hematopoiesis is a continuous process in which hematopoietic stem and progenitor cells (HSPCs) gradually differentiate toward specific lineages. Aging and myeloid malignant transformation are characterized by changes in the...
7.
Muntion S, Preciado S, Sanchez-Luis E, Corchete L, Diez-Campelo M, Osugui L, et al.
Ther Adv Hematol
. 2023 Jan;
13:20406207221142137.
PMID: 36601635
Background: Eltrombopag (EP) is a small molecule that acts directly on hematopoietic stem cells (HSCs) and megakaryocytes to stimulate the hematopoietic process. Mesenchymal stem/stromal cells (MSCs) are key hematopoietic niche...
8.
Marti-Chillon G, Muntion S, Preciado S, Osugui L, Navarro-Bailon A, Gonzalez-Robledo J, et al.
Clin Transl Med
. 2023 Jan;
13(1):e1163.
PMID: 36588089
Background: Despite notable advances in the support and treatment of patients admitted to the intensive care unit (ICU), the management of those who develop a systemic inflammatory response syndrome (SIRS)...
9.
Berastegui N, Ainciburu M, Romero J, Garcia-Olloqui P, Alfonso-Pierola A, Philippe C, et al.
Nat Commun
. 2022 Dec;
13(1):7619.
PMID: 36494342
Myelodysplastic syndromes (MDS) are hematopoietic stem cell (HSC) malignancies characterized by ineffective hematopoiesis, with increased incidence in older individuals. Here we analyze the transcriptome of human HSCs purified from young...
10.
Ibanez-Fonseca A, Rico A, Preciado S, Gonzalez-Perez F, Muntion S, Garcia-Brinon J, et al.
Front Bioeng Biotechnol
. 2022 Jul;
10:918602.
PMID: 35814011
Hindlimb ischemia is an unmet medical need, especially for those patients unable to undergo vascular surgery. Cellular therapy, mainly through mesenchymal stromal cell (MSC) administration, may be a potentially attractive...